InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,967.23
(
-0.88%
)
US TECH 100
16,570.80
(
-2.16%
)
Dow Jones
37,986.40
(
0.56%
)
Brent Oil
86.63
(
0.24%
)
Bitcoin
64,181.00
(
1.06%
)
Post# of 449
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

north40000

Send PM Follow Ignore
Followers 253
Posts 17888
Boards Moderated 0
Alias Born 01/19/2006

north40000

Member Level

Re: Thurly post# 422

Saturday, 11/04/2017 10:39:12 PM

Saturday, November 04, 2017 10:39:12 PM

Post# of 449
See Acad-Pharm.com for PR re phase 2 CTAD PR... news relating to dementia related psychosis treatment results with its BTD medication that is already approved for PD- related psychosis. CORT sp negative past few days...we hold both CORT and ACAD.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CORT News
More CORT News
InvestorsHub NewsWire

VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM

Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM

ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM

Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM

Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM

Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM

Start posting your company's news
Only $200 per official company press release!